BIOCHEMICAL TOPICAL GROUP
The Biochemical Topical Group collaborates with the Biochemistry Section and the Biochemical Pharmacology Discussion Group of The New York Academy of Sciences to sponsor 7 to 8 symposia per year.
The topics and speakers are selected by vote of the membership at the Steering Committee meeting to be held March 25th.
Any scientist may submit a program. The scientist who suggests the topic then chairs that meeting.
The Symposia are held at The New York Academy of Sciences,
7 World Trade Center, and include 4-6 speakers, usually from 1:00 - 5:00 pm.
A coffee break in the middle enables interactions.
We represent a diverse group of scientists with an interest in biochemistry, molecular biology, biomedical research, and related areas.
Members are from pharmaceutical and biotechnology companies, and university and medical center research facilities across the Eastern United States.
Our purpose is to bring together diverse institutions and communities, industrial and academic, to share new and relevant information at the frontiers of research and development.
Download the submission form (.doc format).
For further info please contact:
Dr. Barbara Petrack
Chair, Biochemical Topical Group
Drew University
Dept. RISE
36 Madison Ave, NJ
Madison, NJ 07940
Tel: 973-408-3567
FAX: 973-408-3504
Email
Meetings/Symposia
Spring 2008 Events
April 22, 2008
New Targets in Atherosclerosis
A Symposium Organized by Richard Ingraham (Boehringer Ingelheim Pharmaceuticals, Inc.)
1:00 pm - 5:00 pm
Program
Atherosclerosis is a complicated disease with a relatively small number of cell types involved in lesion pathology.
It has become apparent both from human and animal studies that more that just high LDL levels are involved in the disease process.
It should be possible to target some of the inflammatory and other signaling pathways involved in atherosclerosis downstream from the
stimuli which provoke it and alter or slow disease progression. Recent examples of potential new targets include members of the
5-lipoxygenase pathway which leads to inflammatory leukotrienes and the MAP kinase JNK2 which appears to alter the activities of scavenger receptors.
Inhibition of either pathway seems to inhibit lesion progression. Another well known hypertension target, the angiotensin II pathway,
now appears to be playing a seemingly independent role in promoting plaques formation as well as aneurysm. A greater understanding of
this pathway may also provide us with new approaches to treat atherosclerosis.
Location: The New York Academy of Sciences Conference Center
7 World Trade Center, 250 Greenwich Street - 40th Floor, New York, NY
Directions
Reservations
May 27, 2008
DISC1 and the Developmental Hypothesis of Schizophrenia
A Symposium Organized by Julia Heinrich (Wyeth Discovery Neuroscience) & Robin Kleiman (Pfizer, Inc)
9:00 am - 5:00 pm
Program
Schizophrenia (SZ) is a psychiatric disorder characterized by thought disorder and cognitive deficits.
Currently available antipsychotics provide relief of positive symptoms, but have limited therapeutic
efficacy on negative and cognitive symptoms that typically preclude successful reintegration into society
for many patients. The developmental hypothesis of SZ was originally based on observations that certain
environmental factors and behavioral traits might lead to a predisposition for SZ. More recently it was
broadened to include the influence of SZ susceptibility genes, of which Disrupted in Schizophrenia 1
(DISC1) is one of the most promising candidates. The DISC1 protein functions as a scaffold for multiple
proteins, including nuclear distribution element-like 1 and phosphodiesterase 4B, which themselves
are candidate SZ susceptibility genes. This symposium invites experts in the field of DISC1 biology
to present their ideas on the etiology of SZ and how an understanding of DISC1 regulated pathways
might relate to the development of new antipsychotic therapies.
Location: The New York Academy of Sciences Conference Center
7 World Trade Center, 250 Greenwich Street - 40th Floor, New York, NY
Directions
Reservations
See the current issue of
The Indicator
for meeting information
American Chemical Society
New York Section, Inc.
Department of Chemistry
St. John's University
8000 Utopia Parkway
Jamaica, NY 11439
Phone 516-883-7510
Fax 516-883-4003
E-Mail Inquiries to our Office Administrator
